These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20127030)

  • 1. Pharmacological inhibition of Rho-kinase signaling with Y-27632 blocks melanoma tumor growth.
    Routhier A; Astuccio M; Lahey D; Monfredo N; Johnson A; Callahan W; Partington A; Fellows K; Ouellette L; Zhidro S; Goodrow C; Smith A; Sullivan K; Simone P; Le L; Vezuli B; Zohni M; West E; Gleason D; Bryan B
    Oncol Rep; 2010 Mar; 23(3):861-7. PubMed ID: 20127030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal administration of Y-27632, a specific rho-associated kinase inhibitor, for rat neoplastic meningitis.
    Nakagawa H; Yoshioka K; Miyahara E; Fukushima Y; Tamura M; Itoh K
    Mol Cancer Res; 2005 Aug; 3(8):425-33. PubMed ID: 16123138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organized migration of epithelial cells requires control of adhesion and protrusion through Rho kinase effectors.
    Hopkins AM; Pineda AA; Winfree LM; Brown GT; Laukoetter MG; Nusrat A
    Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G806-17. PubMed ID: 17138966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rho/ROCK and MAPK signaling pathways are involved in glioblastoma cell migration and proliferation.
    Zohrabian VM; Forzani B; Chau Z; Murali R; Jhanwar-Uniyal M
    Anticancer Res; 2009 Jan; 29(1):119-23. PubMed ID: 19331140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of intrahepatic metastasis of human hepatocellular carcinoma by Rho-associated protein kinase inhibitor Y-27632.
    Takamura M; Sakamoto M; Genda T; Ichida T; Asakura H; Hirohashi S
    Hepatology; 2001 Mar; 33(3):577-81. PubMed ID: 11230737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases.
    Ishizaki T; Uehata M; Tamechika I; Keel J; Nonomura K; Maekawa M; Narumiya S
    Mol Pharmacol; 2000 May; 57(5):976-83. PubMed ID: 10779382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Wf-536, a novel ROCK inhibitor, against metastasis of B16 melanoma.
    Nakajima M; Hayashi K; Egi Y; Katayama K; Amano Y; Uehata M; Ohtsuki M; Fujii A; Oshita K; Kataoka H; Chiba K; Goto N; Kondo T
    Cancer Chemother Pharmacol; 2003 Oct; 52(4):319-24. PubMed ID: 12783205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ROCK inhibition and CNTF interact on intrinsic signalling pathways and differentially regulate survival and regeneration in retinal ganglion cells.
    Lingor P; Tönges L; Pieper N; Bermel C; Barski E; Planchamp V; Bähr M
    Brain; 2008 Jan; 131(Pt 1):250-63. PubMed ID: 18063589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rho-kinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells.
    Somlyo AV; Bradshaw D; Ramos S; Murphy C; Myers CE; Somlyo AP
    Biochem Biophys Res Commun; 2000 Mar; 269(3):652-9. PubMed ID: 10720471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The G protein-coupled receptor S1P2 regulates Rho/Rho kinase pathway to inhibit tumor cell migration.
    Lepley D; Paik JH; Hla T; Ferrer F
    Cancer Res; 2005 May; 65(9):3788-95. PubMed ID: 15867375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E1AF/PEA3 activates the Rho/Rho-associated kinase pathway to increase the malignancy potential of non-small-cell lung cancer cells.
    Hakuma N; Kinoshita I; Shimizu Y; Yamazaki K; Yoshida K; Nishimura M; Dosaka-Akita H
    Cancer Res; 2005 Dec; 65(23):10776-82. PubMed ID: 16322223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Rho-kinase inhibitor Y-27632 inhibits cholestasis-induced platelet interactions in the hepatic microcirculation.
    Laschke MW; Dold S; Menger MD; Jeppsson B; Thorlacius H
    Microvasc Res; 2009 Jun; 78(1):95-9. PubMed ID: 19374910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RhoA induces expression of inflammatory cytokine in adipocytes.
    Nakayama Y; Komuro R; Yamamoto A; Miyata Y; Tanaka M; Matsuda M; Fukuhara A; Shimomura I
    Biochem Biophys Res Commun; 2009 Feb; 379(2):288-92. PubMed ID: 19101507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement on primate corneal endothelial cell survival in vitro by a ROCK inhibitor.
    Okumura N; Ueno M; Koizumi N; Sakamoto Y; Hirata K; Hamuro J; Kinoshita S
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3680-7. PubMed ID: 19387080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of the effects of Y-27632.
    Darenfed H; Dayanandan B; Zhang T; Hsieh SH; Fournier AE; Mandato CA
    Cell Motil Cytoskeleton; 2007 Feb; 64(2):97-109. PubMed ID: 17009325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rho-associated kinase inhibitor Y-27632 promotes survival of cynomolgus monkey embryonic stem cells.
    Takehara T; Teramura T; Onodera Y; Kakegawa R; Fukunaga N; Takenoshita M; Sagawa N; Fukuda K; Hosoi Y
    Mol Hum Reprod; 2008 Nov; 14(11):627-34. PubMed ID: 18940855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of rho-associated protein kinase inhibitor Y-27632 on intraocular pressure and outflow facility.
    Honjo M; Tanihara H; Inatani M; Kido N; Sawamura T; Yue BY; Narumiya S; Honda Y
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):137-44. PubMed ID: 11133858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632.
    Rao PV; Deng PF; Kumar J; Epstein DL
    Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):1029-37. PubMed ID: 11274082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine-oligoarginine conjugate, a novel bisubstrate inhibitor, effectively dissociates the actin cytoskeleton.
    Räägel H; Lust M; Uri A; Pooga M
    FEBS J; 2008 Jul; 275(14):3608-24. PubMed ID: 18540886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylated caveolin-1 regulates Rho/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasion.
    Joshi B; Strugnell SS; Goetz JG; Kojic LD; Cox ME; Griffith OL; Chan SK; Jones SJ; Leung SP; Masoudi H; Leung S; Wiseman SM; Nabi IR
    Cancer Res; 2008 Oct; 68(20):8210-20. PubMed ID: 18922892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.